CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 13,706	$ 10,361
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,435	643
Inventory impairment charges	503	8
Share-based compensation	12,415	0
Amortization of discount and cost of issuance of debt	0	72
Bad debts	24	49
Non-cash interest expense	0	202
(Gain) loss from change in fair value remeasurement of SAFEs	0	(19,100)
(Gain) loss from change in fair value of warrants	(47,353)	0
(Gain) loss from change in fair value of contingent consideration and earn-out liability	(83)	0
Accrued contingent consideration related to acquisition	0	60
Deferred City Semi compensation	125	125
Amortization of right-of-use assets	469	0
Unrealized foreign currency transaction (gain) loss	(14)	0
Changes in operating assets and liabilities:
Accounts receivable	(1,796)	(1,163)
Inventory	(235)	(746)
Accounts payable	1,271	536
Accrued expenses and other current liabilities	1,037	266
Accrued payroll liabilities	(1,820)	166
Deferred revenue	1,792	(564)
Prepaid and other current assets	(789)	(6)
Operating lease liabilities	(144)	0
Other long-term liabilities	(257)	0
Net cash used in operating activities	(15,714)	(9,091)
Cash flows from investing activities:
Purchases of property and equipment	(565)	(140)
Accrual for purchases of intangible assets	0	(21)
Business combinations, net of cash	(8,705)	0
Net cash used in investing activities	(9,270)	(161)
Cash flows from financing activities:
Proceeds from issuance of debt obligations	315	0
Payments on debt obligations	(383)	0
Payments on financed software	(704)	(300)
Payments on deferred financing costs	0	(332)
Proceeds from exercise of stock options	52	0
Net cash used in financing activities	(720)	(632)
Effect of exchange rate changes on cash and cash equivalents	(398)	59
Net increase in cash and cash equivalents	(26,102)	(9,825)
Cash, cash equivalents and restricted cash at beginning of period	219,464	18,698
Cash, cash equivalents and restricted cash at end of period	193,362	8,873
Supplemental disclosure of cash flow information:
Cash paid for interest	58	340
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	39	56
Deferred financing costs incurred	0	491
Contingent consideration for business combination	8,204	0
Accrual for purchase consideration for business combination	$ 9,674	$ 0